Bio Medica Laboratories Limited

₹153.30As of Sun 8 Nov 2026, 12:00 UTC
NSE:BMLLHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 67.79%
Pharmaceutical Preparations
Beta (5Y) —
PE TTM 11.95
TSR TTM —
Mkt cap ₹1.928B
ROIC 30.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹157
2.26%
42.22%
Hold 6|11|1|1|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.69
1.72
1.90
1.83
12.06%
12.18%
29.13%
12.53%
Revenue₹M
89.97
94.51
99.61
98.35
0.71%
5.88%
7.22%
7.14%
Peers (US$19.46M)
Cap (US$)
PE
18.95M
9.266x
18.82M
5.918x
19.32M
8.765x
Capital
TTM
5Y
10Y
Leveragex
2.199
(0.072)
(0.071)
EBIT/Intx
0.493
6.827
6.617
Own earn%
(33.20)
208.11
169.89
Sh yield%
27.25
31.66
28.38
Owners
Insiders/Inst%
6.86
21.98
Short interest%
2.25
SBC / revenue%
5.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
0–2
$1 testx
—
Incr. ROIC%
44